Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCY8V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,970
Award facts
- Contract value 100% obligated
- $36,969.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,969.64 delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of BIMZELX 320 mg/2 mL auto-injector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 12, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, particularly those supporting military and veteran populations.
This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. BIMZELX is a prescription biologic medication used in the treatment of inflammatory conditions, and this procurement demonstrates the contractor's ongoing role in fulfilling critical medical commodity requirements for federal defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FCY8V?
SPE2DR26FCY8V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FCY8V worth?
The government has obligated $36,970 on SPE2DR26FCY8V.
Is contract SPE2DR26FCY8V an order under another contract?
Yes. SPE2DR26FCY8V is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY8V competed?
The extent of competition for SPE2DR26FCY8V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award